← Evidence map

ArticleCancer biology & therapy2017

LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.

Baoli Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

68 papers cite itlatest 60 shown

2017
…
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29020498